COVID-19 infections produce antibodies that persist and reduce reinfection risk for up to six months
by Press Release from Outbreak News Today on (#5PHET)
A Michigan Medicine study found that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months. Researchers analyzed nearly 130 subjects with PCR-confirmed COVID-19 illness between three and six months after initial infection. Three patients were hospitalized while the rest were treated as outpatients and [...]
The post COVID-19 infections produce antibodies that persist and reduce reinfection risk for up to six months appeared first on Outbreak News Today.